In children who presented with concomitant allergic cutaneous and respiratory diseases (BA and AD), the overexpression of CCL28 can be ascribed to the presence of AD, supporting further evidence for the implication of CCL28 in atopic cutaneous responses. This evidence concerns the gene CCL28 and breast angiosarcoma.